null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

PD-L2/CD273 Monoclonal Antibody (CAB23287)

SKU CAB23287
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Rabbit
Isotype IgG
Applications WB
Applications IHC
€139 - €529
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PD-L2/CD273 Monoclonal Antibody (CAB23287)

The PD-L2 (CD273) Monoclonal Antibody is a research tool specifically designed for studying the programmed death ligand 2 (PD-L2) protein, a key player in immune regulation and tolerance. This monoclonal antibody, produced using hybridoma technology, exhibits high specificity and sensitivity for detecting PD-L2 in various biological samples.PD-L2, also known as CD273, is an immune checkpoint molecule that interacts with its receptor PD-1 to suppress immune responses, playing a critical role in immune evasion and immune tolerance in the context of cancer and autoimmune diseases. The PD-L2 Monoclonal Antibody enables researchers to detect and analyze PD-L2 expression in cells and tissues, providing valuable insights into its function in immunology and cancer biology.

By understanding the role of PD-L2 in immune regulation and its impact on the tumor microenvironment, researchers can develop targeted therapies that modulate the PD-1/PD-L1/PD-L2 axis to enhance anti-tumor immune responses and potentially improve clinical outcomes in cancer patients. Additionally, studying PD-L2 expression and function may lead to the identification of novel therapeutic targets and biomarkers for predicting response to immunotherapy treatments.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose